01
Mr Richard D Lapthorne CBE
Bcom, FCMA, FCCA, FCT, CBIM
Non-Executive Chairman
Chairman of the Board in 1996 and again since 1999, Deputy Chairman from 1997 to 1999 and a Board member since joining Amersham International plc as a Non-Executive Director in 1988. Mr Lapthorne will be retiring from the Board after the Annual General Meeting on 7 May 2003. Recruited as Finance Director of British Aerospace plc in July 1992, becoming Vice Chairman in April 1998. Retired from British Aerospace in September 1999. Also serves as Non-Executive Chairman of Cable and Wireless from 10 January 2003, Morse plc, Avecia Limited, Tunstall Holdings Limited, TI Automotive Limited and a Non-Executive Director of Oasis International Leasing in Abu Dhabi. Age 59.

02
Mr Johan Fr Odfjell Siv.øk., MBA
Non-Executive Deputy Chairman
Deputy Chairman of the Board since 1999. From 1997 to 1999 served as Chairman of the Board, and from 1996 as a non-executive board member of Nycomed ASA. Served as Chief Executive of Vesta Insurance Group from 1986 to 1994. From 1994 has combined his own consultancy and investment firm with several non-executive board positions. Also Chairman of Orkla ASA, Star Shipping A/S and Nera ASA. Co-Chairman of Det Norske Veritas; and a board member of Bergesen ASA. Age 54.

03
Mr Donald H Brydon OBE, BSc
Non-Executive Director Chairman Designate
A Non-Executive Director since 1997 and will succeed Richard Lapthorne as Chairman following the Annual General Meeting in May 2003. Joined AXA Group in 1997 after a 20-year career with the Barclays Group. Now serving as Chairman of AXA Investment Managers, and a non-executive director of Allied Domecq and Chairman of the Financial Services Practitioner Panel. Age 57.

04
Mr George Battersby BSc
Human Resources Director
Joined the company in 2000 as Human Resources Director. Previously with Laporte plc from 1996 to 2000 as Human Resources Director, and Fisons plc from 1985 to 1996 as Group Human Resources Director. Earlier career included sales and marketing, consulting and human resources appointments in companies including International Computers Limited and Air Products and Chemicals Inc. Age 56.

05
Dr Andrew Carr Ph.D
President,Amersham Biosciences
Joined the company in 1987 as Senior Development Scientist and has held a number of senior management positions in research and development, manufacturing, and sales and marketing. Appointed President of Amersham Biosciences in 2000 and joined the Board in May 2002. Age 43.

06
Sir William Castell BA, FCA
Chief Executive
Chief Executive since 1989, when he joined Amersham International plc. Previously Commercial Director Wellcome plc 1987-1989, following a career in Wellcome spanning over twenty years. Also serves as Chairman of The Prince’s Trust and Council Member of the Medical Research Council, and is on the External Advisory Board for the Life Sciences Institute at Michigan. Knighted in June 2000 for services to the life sciences industry. Age 55.

07
Mr John H Johansen MSc
Non-Executive Director
A Non-Executive Director since 1997, having served on the Hafslund Nycomed ASA board since 1994 as an elected employee representative. Joined the Norwegian organisation in 1980 as a Research Scientist, peptide chemistry, holding management positions in chemistry research and development. A Senior Research Scientist in Amersham Health from 1991 to the present. Appointed a member of the board of Playboard Magazine AS in 2001. Age 56.

08
Mr Giles F B Kerr BA, ACA
Finance Director
Appointed Finance Director in 1997. Joined Amersham International plc as Group Financial Controller 1991 to 1994, Commercial Controller 1994 to 1996, Company Secretary and Director of Corporate Development 1996 to 1997. Worked for Arthur Andersen & Co from 1981, in positions including Audit and Accounting Manager and Partner, Corporate Finance and Investigations. Age 43.

09
Mr Peter Loescher MBA
President, Amersham Health
Joined the company in December 2002. Previously with Hoechst AG and its successor company Aventis working in a variety of roles in Germany, Japan, Spain, UK, and USA. From 1999 to 2002 served as Chairman and Chief Executive Officer of Aventis Pharma in Japan, having previously served as Chief Executive Officer of Hoechst Marion Roussell Limited in the UK from 1997. Age 45.

10
Dr John S Patterson FRCP
Non-Executive Director
A Non-Executive Director since 2001. Appointed Vice President for Clinical Research and Medical Affairs of ICI Pharmaceuticals for the USA in 1988 after a long career with the company. In 1990 joined its board as Medical Director. Appointed Executive Vice President Product Strategy and Licensing for AstraZeneca in 1999 and currently serves as Chair on its Portfolio Management and Licensing Executive subcommittees. Also serves as a Director of the British Pharmaceuticals Group and is President of the Association of the British Pharmaceutical Industry. Age 55.

11
Sir Keith Peters MB BCh, FRCP, FRCPath, FRS
Non-Executive Director
A Non-Executive Director since 2000. Also Chairman of the Amersham plc Science Advisory Board and a member of the Amersham plc Portfolio Committee. Became Regius Professor of Physic at the University of Cambridge in 1987. President, Academy of Medical Sciences; Honorary Consultant Physician at Addenbroke’s NHS Trust. Governing Trustee, The Nuffield Trust; Trustee, Strangeways Research Laboratory. Member of Council of Heads of Medical Schools and Deans of UK Faculties of Medicine; member of Scientific Advisory Boards of the Gairdner Foundation, Merck Institute, Merck Sharp & Dohme Research Laboratories Neuroscience Research Centre and Cambridge Antibody Technology.
Age 64.

12
Mr Jacques F Rejeange MBA
Non-Executive Director
A Non-Executive Director since 1997, having been a non-executive board member of Hafslund Nycomed ASA since 1994. From 1966 to 1992 was employed by the Sandoz Group, rising from Management Trainee to President and Chief Executive of Sandoz Pharmaceuticals Inc in the USA. Became President and Chief Executive of Sterling Winthrop Inc in 1994 and in 1998 until June 2002 was Chief Executive of NMT Management AG. Also a non-executive director of Antares Inc and Pozen Inc, both in the USA. Age 63.

13
Professor Erik Thorsby MD
Non-Executive Director
A Non-Executive Director since 1997, having earlier that year joined the Nycomed ASA board as a non-executive member. Held a number of positions in medical institutions, international scientific societies and committees and in 1983 was appointed Professor of Medicine at the University of Oslo. Currently Head of the Institute of Immunology at The National Hospital and University of Oslo. Also serves as President of the European Federation for Immunogenetics and is Chairman of the Research Council at The National Hospital. Age 64.

14
Professor Mathias Uhlén
Non-Executive Director
Appointed Non-Executive Director in May 2002, having served as a Non-Executive Director of Amersham Biosciences since 1997 and a member of the Amersham plc Portfolio Committee. Professor of Biotechnology at the Royal Institute of Technology (KTH) Stockholm since 1988. Serves on the boards of Magnetic Biosolutions AB, Prevas AB, Personal Chemistry AB, Skanditec AB, Affibody AB, Pyrosequencing AB, Biovitrum AB and KTH Holding AB. Age 48.